MUSC Hollings Cancer Center - Report to the Community 2026 - Flipbook - Page 12
Faculty Highlights
The Zucker Institute for Innovation Commercialization (ZI) independently evaluates and manages
the intellectual assets owned and generated by MUSC. The institute held an awards ceremony
and recognized the following Hollings researchers for their achievements.
PAT E N T H O L D E R S
Besim Ogretmen, Ph.D.
Natalia Oleinik, Ph.D.
Zdzislaw Szulc, Ph.D.
(not pictured)
Honored for “Sphingolipid-based
selenium compounds, methods for
their preparation and pharmaceutical
uses thereof, including as
antitumor agents.”
ENTREPRENEUR OF THE YEAR
Nate Dolloff, Ph.D.
Recognized for his entrepreneurship.
The lead asset of his startup,
Leukogene Therapeutics, was granted
orphan drug designation by the FDA.
N AT I O N A L A C A D E M Y O F I N V E N T O R S
John O’Bryan, Ph.D.
I N N O VAT O R O F T H E Y E A R
Leonardo Ferreira, Ph.D.
Honored as the Admiral Albert J.
Baciocco innovator of the year.
10 | MUSC Hollings Cancer Center
Inducted as a new member of the John
N. Vournakis chapter.
P AT E N T H O N O R E E
Honored for “Compositions and
methods targeting the nucleotidefree state of RAS to block oncogenic
signaling and transformation.”